Sign in

CIK 0001526119

  • Non-accelerated filer
  • Smaller reporting company

Verastem, Inc.

Sign in to watch
Ticker
VSTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
273269467
Phone
+1 781-292-4200
Business address
117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$386,390
in 4 filings, $386K under 10b5-1 plans

Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2012-03-06 GADICKE ANSBERT Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2012-02-01 GADICKE ANSBERT Director Conversion +1,142,857 1,142,857
2012-02-01 GADICKE ANSBERT Director Conversion +714,286 1,857,143
2012-02-01 GADICKE ANSBERT Director Conversion +76,190 1,933,333
2012-02-01 GADICKE ANSBERT Director Purchase +96,260 $10.00 $963K 2,029,593
2012-02-01 GADICKE ANSBERT Director Purchase +3,740 $10.00 $37K 3,740
2012-02-01 GADICKE ANSBERT Director Conversion · Series A Preferred Stock −4,000,000 0
2012-02-01 GADICKE ANSBERT Director Conversion · Series B Preferred Stock −2,500,000 0
2012-02-01 GADICKE ANSBERT Director Conversion · Series C Preferred Stock −266,666 0

Page 1 of 1 · 9 trades